Tuesday, November 27, 2018 5:41:18 PM
As you say, it is the uncertainty of working with a 3rd world country and the failure of Noreen and the board to keep the investor informed.
And realistically, as hopeful as I am about Cytocom, I am in the: "when it actually happens, I will believe it.
Because until I see Noreen's name removed from anything to do with Cytocom, and no longer CEO of IMUN, these companies will continue on the same path they have for years....all talk, but no action, no revenue.
You know how you know if Noreen is lying....her lips are moving.
Her talents are for deal making. She is that unscrupulous snake, who could sell a glass of ice water to an Eskimo. However, she had no place as a CEO in any company. She only brings destruction to stock value, investor value and company value.
And now....the destruction of every investor who had faith she would stand by all of us, and make decisions that were beneficial to all of us, not just Herself, the board, and the large investors.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM